View Post

Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States. Journal of Acquired Immune Deficiency Syndrome, 53(5): 614-618.

In by AHFApril 1, 2010